BioSpace News Archive

BioMidwest

DirectRx Pharmacy Launches DirectFlow Technology to Streamline Provider Communications

Independent specialty pharmacy DirectRx announced today the launch and implementation of DirectFlow technology, designed to streamline the process of communicating patient information between physicians’ offices and the DirectRx pharmacy team.

April 4, 2022
·
1 min read
Drug Development

Inozyme Pharma Announces Positive Preliminary Data from Phase 1/2 Clinical Trial of INZ-701 in Patients with ENPP1 Deficiency

Inozyme Pharma, Inc. today announced positive preliminary biomarker, safety, and pharmacokinetic (PK) data from the first three patients treated in the Phase 1 portion of its ongoing first-in-human Phase 1/2 clinical trial of INZ-701 in adult patients with ENPP1 Deficiency.

April 4, 2022
·
10 min read
Pharm Country

Applied Therapeutics to Present at the 43rd Annual Meeting of the Society for Inherited Metabolic Disorders

Applied Therapeutics, Inc. today announced poster presentations at the 2022 43rd Annual Meeting of the Society for Inherited Metabolic Disorders, April 10 - 13, 2022 in Orlando, Florida.

April 4, 2022
·
4 min read
Drug Development

Wave Life Sciences Announces Positive Update to Ongoing Phase 1b/2a FOCUS-C9 Study Driven by Potent, Durable Reductions of Poly(GP) with Low, Single Doses of WVE-004

Wave Life Sciences Ltd. today announced a positive update to the ongoing Phase 1b/2a FOCUS-C9 trial of WVE-004, the company’s clinical candidate for C9orf72-associated amyotrophic lateral sclerosis (C9-ALS) and frontotemporal dementia (C9-FTD).

April 4, 2022
·
13 min read
Deals

AnPac Bio Filed Request for a Hearing Regarding Continued Listing on NASDAQ, The Hearing was Granted and scheduled for Late April

AnPac Bio-Medical Science Co., Ltd. announced that on April 1, 2022, the Company received a Nasdaq Hearing Instructions letter (the “Letter”) from the Nasdaq Stock Market LLC.

April 4, 2022
·
6 min read
Business

Meridian Michigan Announces Appointment of New Chief Medical Officer

Meridian Michigan announced today that it has appointed Dr. Kay Judge as its new Chief Medical Officer, effective April 10 , 2022.

April 4, 2022
·
2 min read
PERRIGO ANNOUNCES LAUNCH OF PRIVATE NOTES OFFERING

Perrigo Company plc today announced that it has launched a private offering (the “Offering”) of $500 million aggregate principal amount of senior notes due 2030,

April 4, 2022
·
7 min read
Genetown

Alnylam Announces 3-Month Extension of Review Period for New Drug Application for Vutrisiran

Alnylam Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has extended the review timeline of the New Drug Application (NDA) for vutrisiran.

April 4, 2022
·
7 min read
Biotech Bay

Aspen Surgical Receives Additional Investment from Audax Private Equity through Single-Asset Continuation Vehicle

Aspen Surgical Products announced today that Audax has closed on a single-asset continuation fund to support additional investment in Aspen, reaffirming its commitment to the company’s growth strategy.

April 4, 2022
·
4 min read
Drug Development

TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis Presented at the American Academy of Neurology Annual Meeting

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced data from the ULTIMATE I & II Phase 3 trials evaluating ublituximab in patients with relapsing forms of multiple sclerosis (RMS), presented over the weekend at the American Academy of Neurology (AAN) annual meeting, held in Seattle, Washington.

April 4, 2022
·
10 min read